Armodafinil is a wakefulness-promoting agent prescribed for conditions like narcolepsy, obstructive sleep apnea, and shift work sleep disorder [1]. The 150 mg tablet strength is a common dosage form [2].
What are the approved uses for Armodafinil 150 mg?
Armodafinil 150 mg tablets are indicated to improve wakefulness in adult patients with narcolepsy, obstructive sleep apnea (OSA), and shift work sleep disorder (SWSD) [1]. For OSA, it is used as an adjunct to primary sleep apnea treatments like continuous positive airway pressure (CPAP) when CPAP alone is insufficient [1].
How does Armodafinil work?
The exact mechanism of action for armodafinil is not fully understood [1]. It is believed to affect dopamine levels in the brain and may modulate other neurotransmitter systems, contributing to its wakefulness-promoting effects [1].
When does the patent for Armodafinil expire?
Patents related to armodafinil have been subject to expiration and challenges. Information on specific patent expiry dates can be found on resources like DrugPatentWatch.com [3].
What are the potential side effects of Armodafinil 150 mg?
Common side effects of armodafinil can include headache, nausea, nervousness, dizziness, and trouble sleeping [1]. Serious side effects, though less common, can include severe rashes and allergic reactions, as well as psychiatric symptoms like anxiety, hallucinations, and suicidal thoughts [1].
Are there generic versions of Armodafinil available?
Yes, generic versions of armodafinil are available. The availability of generics can impact pricing and accessibility [4].
What is the difference between Armodafinil and Modafinil?
Armodafinil is the R-enantiomer of modafinil, meaning it is a specific stereoisomer of the original drug. It is thought to provide a longer duration of action compared to modafinil [5].
Who manufactures Armodafinil?
The original brand-name armodafinil is sold as Nuvigil [1]. Numerous pharmaceutical companies manufacture generic versions of armodafinil [4].
What clinical data supports the use of Armodafinil 150 mg?
Clinical trials have demonstrated armodafinil's efficacy in improving wakefulness in patients with narcolepsy, OSA, and SWSD. These studies often measure improvements in sleep latency and patient-reported wakefulness [1].
What are the risks associated with taking Armodafinil?
Potential risks include the development of serious skin reactions, cardiovascular events, and psychiatric issues. Patients with pre-existing heart conditions should use armodafinil with caution [1].
How should Armodafinil 150 mg be taken?
Armodafinil 150 mg tablets are typically taken once daily in the morning. For SWSD, it is taken approximately one hour before the start of the work shift. It should be taken with or without food [1].
Sources:
[1] https://www.drugs.com/armodafinil.html
[2] https://www.webmd.com/drugs/2/155680/armodafinil-oral
[3] https://drugpatentwatch.com/
[4] https://www.goodrx.com/armodafinil
[5] https://www.rxlist.com/armodafinil-side-effects-drug-center.htm